Long-Term Follow-up of Barrett's Epithelium

Medical Versus Antireflux Surgical Therapy

Giovanni Zaninotto, Paola Parente, Renato Salvador, Fabio Farinati, Chiara Tieppo, Nicola Passuello, Lisa Zanatta, Matteo Fassan, Francesco Cavallin, Mario Costantini, Claudia Mescoli, Giorgio Battaglia, Alberto Ruol, Ermanno Ancona, Massimo Rugge

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Barrett's esophagus (BE) is the most serious complication of GERD. In BE patients, this observational study compares the effects of antireflux surgery versus antisecretory medical therapy. Methods: Overall, 89 BE patients (long BE = 45; short BE = 44) were considered: 45 patients underwent antireflux surgery and 44 underwent medical therapy. At both initial and follow-up endoscopy, symptoms were assessed using a detailed questionnaire; BE phenotypic changes [intestinal metaplasia (IM) presence/type, Cdx2 expression] were assessed by histology (H&E), histochemistry (HID), and immunohistochemistry. Surgical failures were defined as follows: (1) abnormal 24-h pH monitoring results after surgery, (2) endoscopically evident recurrent esophagitis, and (3) recurrent hiatal hernia or slipped fundoplication on endoscopy or barium swallow. Results: Reversion of IM was observed in 12/44 SSBE and 0/45 LSBE patients (p <0. 01). Reversion was more frequently observed after effective antireflux surgery than after medical treatment (p = 0. 04). In patients with no further evidence of IM after therapy, Cdx2 expression was also absent (p = 0. 02). The extent of IM was reduced, and the IM phenotype improved in SSBE patients after surgery. Conclusions: Patients with short BE (but not those with long BE) may benefit from surgically reducing the esophagus' exposure to GE reflux; among these patients, successful surgery carries a higher IM reversion rate than medical treatment.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalJournal of Gastrointestinal Surgery
Volume16
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Barrett Esophagus
Metaplasia
Therapeutics
Endoscopy
Fundoplication
Hiatal Hernia
Esophagitis
Barium
Deglutition
Gastroesophageal Reflux
Esophagus
Observational Studies
Histology
Immunohistochemistry
Phenotype

Keywords

  • Barrett's esophagus
  • Fundoplication
  • GERD
  • PPI

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Zaninotto, G., Parente, P., Salvador, R., Farinati, F., Tieppo, C., Passuello, N., ... Rugge, M. (2012). Long-Term Follow-up of Barrett's Epithelium: Medical Versus Antireflux Surgical Therapy. Journal of Gastrointestinal Surgery, 16(1), 7-15. https://doi.org/10.1007/s11605-011-1739-8

Long-Term Follow-up of Barrett's Epithelium : Medical Versus Antireflux Surgical Therapy. / Zaninotto, Giovanni; Parente, Paola; Salvador, Renato; Farinati, Fabio; Tieppo, Chiara; Passuello, Nicola; Zanatta, Lisa; Fassan, Matteo; Cavallin, Francesco; Costantini, Mario; Mescoli, Claudia; Battaglia, Giorgio; Ruol, Alberto; Ancona, Ermanno; Rugge, Massimo.

In: Journal of Gastrointestinal Surgery, Vol. 16, No. 1, 01.2012, p. 7-15.

Research output: Contribution to journalArticle

Zaninotto, G, Parente, P, Salvador, R, Farinati, F, Tieppo, C, Passuello, N, Zanatta, L, Fassan, M, Cavallin, F, Costantini, M, Mescoli, C, Battaglia, G, Ruol, A, Ancona, E & Rugge, M 2012, 'Long-Term Follow-up of Barrett's Epithelium: Medical Versus Antireflux Surgical Therapy', Journal of Gastrointestinal Surgery, vol. 16, no. 1, pp. 7-15. https://doi.org/10.1007/s11605-011-1739-8
Zaninotto, Giovanni ; Parente, Paola ; Salvador, Renato ; Farinati, Fabio ; Tieppo, Chiara ; Passuello, Nicola ; Zanatta, Lisa ; Fassan, Matteo ; Cavallin, Francesco ; Costantini, Mario ; Mescoli, Claudia ; Battaglia, Giorgio ; Ruol, Alberto ; Ancona, Ermanno ; Rugge, Massimo. / Long-Term Follow-up of Barrett's Epithelium : Medical Versus Antireflux Surgical Therapy. In: Journal of Gastrointestinal Surgery. 2012 ; Vol. 16, No. 1. pp. 7-15.
@article{c62358782b6440efa8124a03fbee8302,
title = "Long-Term Follow-up of Barrett's Epithelium: Medical Versus Antireflux Surgical Therapy",
abstract = "Background: Barrett's esophagus (BE) is the most serious complication of GERD. In BE patients, this observational study compares the effects of antireflux surgery versus antisecretory medical therapy. Methods: Overall, 89 BE patients (long BE = 45; short BE = 44) were considered: 45 patients underwent antireflux surgery and 44 underwent medical therapy. At both initial and follow-up endoscopy, symptoms were assessed using a detailed questionnaire; BE phenotypic changes [intestinal metaplasia (IM) presence/type, Cdx2 expression] were assessed by histology (H&E), histochemistry (HID), and immunohistochemistry. Surgical failures were defined as follows: (1) abnormal 24-h pH monitoring results after surgery, (2) endoscopically evident recurrent esophagitis, and (3) recurrent hiatal hernia or slipped fundoplication on endoscopy or barium swallow. Results: Reversion of IM was observed in 12/44 SSBE and 0/45 LSBE patients (p <0. 01). Reversion was more frequently observed after effective antireflux surgery than after medical treatment (p = 0. 04). In patients with no further evidence of IM after therapy, Cdx2 expression was also absent (p = 0. 02). The extent of IM was reduced, and the IM phenotype improved in SSBE patients after surgery. Conclusions: Patients with short BE (but not those with long BE) may benefit from surgically reducing the esophagus' exposure to GE reflux; among these patients, successful surgery carries a higher IM reversion rate than medical treatment.",
keywords = "Barrett's esophagus, Fundoplication, GERD, PPI",
author = "Giovanni Zaninotto and Paola Parente and Renato Salvador and Fabio Farinati and Chiara Tieppo and Nicola Passuello and Lisa Zanatta and Matteo Fassan and Francesco Cavallin and Mario Costantini and Claudia Mescoli and Giorgio Battaglia and Alberto Ruol and Ermanno Ancona and Massimo Rugge",
year = "2012",
month = "1",
doi = "10.1007/s11605-011-1739-8",
language = "English",
volume = "16",
pages = "7--15",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - Long-Term Follow-up of Barrett's Epithelium

T2 - Medical Versus Antireflux Surgical Therapy

AU - Zaninotto, Giovanni

AU - Parente, Paola

AU - Salvador, Renato

AU - Farinati, Fabio

AU - Tieppo, Chiara

AU - Passuello, Nicola

AU - Zanatta, Lisa

AU - Fassan, Matteo

AU - Cavallin, Francesco

AU - Costantini, Mario

AU - Mescoli, Claudia

AU - Battaglia, Giorgio

AU - Ruol, Alberto

AU - Ancona, Ermanno

AU - Rugge, Massimo

PY - 2012/1

Y1 - 2012/1

N2 - Background: Barrett's esophagus (BE) is the most serious complication of GERD. In BE patients, this observational study compares the effects of antireflux surgery versus antisecretory medical therapy. Methods: Overall, 89 BE patients (long BE = 45; short BE = 44) were considered: 45 patients underwent antireflux surgery and 44 underwent medical therapy. At both initial and follow-up endoscopy, symptoms were assessed using a detailed questionnaire; BE phenotypic changes [intestinal metaplasia (IM) presence/type, Cdx2 expression] were assessed by histology (H&E), histochemistry (HID), and immunohistochemistry. Surgical failures were defined as follows: (1) abnormal 24-h pH monitoring results after surgery, (2) endoscopically evident recurrent esophagitis, and (3) recurrent hiatal hernia or slipped fundoplication on endoscopy or barium swallow. Results: Reversion of IM was observed in 12/44 SSBE and 0/45 LSBE patients (p <0. 01). Reversion was more frequently observed after effective antireflux surgery than after medical treatment (p = 0. 04). In patients with no further evidence of IM after therapy, Cdx2 expression was also absent (p = 0. 02). The extent of IM was reduced, and the IM phenotype improved in SSBE patients after surgery. Conclusions: Patients with short BE (but not those with long BE) may benefit from surgically reducing the esophagus' exposure to GE reflux; among these patients, successful surgery carries a higher IM reversion rate than medical treatment.

AB - Background: Barrett's esophagus (BE) is the most serious complication of GERD. In BE patients, this observational study compares the effects of antireflux surgery versus antisecretory medical therapy. Methods: Overall, 89 BE patients (long BE = 45; short BE = 44) were considered: 45 patients underwent antireflux surgery and 44 underwent medical therapy. At both initial and follow-up endoscopy, symptoms were assessed using a detailed questionnaire; BE phenotypic changes [intestinal metaplasia (IM) presence/type, Cdx2 expression] were assessed by histology (H&E), histochemistry (HID), and immunohistochemistry. Surgical failures were defined as follows: (1) abnormal 24-h pH monitoring results after surgery, (2) endoscopically evident recurrent esophagitis, and (3) recurrent hiatal hernia or slipped fundoplication on endoscopy or barium swallow. Results: Reversion of IM was observed in 12/44 SSBE and 0/45 LSBE patients (p <0. 01). Reversion was more frequently observed after effective antireflux surgery than after medical treatment (p = 0. 04). In patients with no further evidence of IM after therapy, Cdx2 expression was also absent (p = 0. 02). The extent of IM was reduced, and the IM phenotype improved in SSBE patients after surgery. Conclusions: Patients with short BE (but not those with long BE) may benefit from surgically reducing the esophagus' exposure to GE reflux; among these patients, successful surgery carries a higher IM reversion rate than medical treatment.

KW - Barrett's esophagus

KW - Fundoplication

KW - GERD

KW - PPI

UR - http://www.scopus.com/inward/record.url?scp=84855346753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855346753&partnerID=8YFLogxK

U2 - 10.1007/s11605-011-1739-8

DO - 10.1007/s11605-011-1739-8

M3 - Article

VL - 16

SP - 7

EP - 15

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 1

ER -